DiagnoCure Overview
- Year Founded
-
1994
- Status
-
Public
- Employees
-
11
- Stock Symbol
-
DGCRF
- Investments
-
1
DiagnoCure General Information
Description
Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.
Contact Information
Website
www.diagnocure.comCorporate Office
- 4535 Wilfrid-Hamel Boulevard
- Suite 250
- Quebec, Quebec G1P 2J7
- Canada
Corporate Office
- 4535 Wilfrid-Hamel Boulevard
- Suite 250
- Quebec, Quebec G1P 2J7
- Canada
DiagnoCure Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 2.31K |
DiagnoCure Financials Summary
As of 31-Jul-2016, DiagnoCure has a trailing 12-month revenue of $5.02M.
|
In Thousands, USD |
TTM 31-Jul-2016 | FY 2015 31-Oct-2015 | FY 2014 31-Oct-2014 | FY 2013 31-Oct-2013 |
|---|---|---|---|---|
| EV | (308) | 7,450 | 7,563 | 11,604 |
| Revenue | 5,024 | 416 | 507 | 658 |
| EBITDA | 2,416 | (2,624) | (1,582) | (2,704) |
| Net Income | 2,060 | (2,909) | (1,864) | (3,497) |
| Total Assets | 410 | 1,369 | 4,940 | 7,488 |
| Total Debt | 0 | 14 | 48 | 81 |
DiagnoCure Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
DiagnoCure Patents
DiagnoCure Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2875157-A1 | Methods, kits and compositions for providing a clinical assessment of prostate cancer | Inactive | 20-Jul-2012 | ||
| EP-2875157-A4 | Methods, kits and compositions for providing a clinical assessment of prostate cancer | Inactive | 20-Jul-2012 | ||
| US-20150218646-A1 | Methods, kits and compositions for providing a clinical assessment of prostate cancer | Inactive | 20-Jul-2012 | ||
| CA-2879557-A1 | Methods, kits and compositions for providing a clinical assessment of prostate cancer | Inactive | 20-Jul-2012 | ||
| AU-2010217160-B2 | Method for detecting metastasis of gi cancer | Inactive | 25-Feb-2009 | G01N33/57419 |
DiagnoCure Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
DiagnoCure Acquisitions (1)
DiagnoCure’s most recent deal was a Merger/Acquisition with Catalyst Oncology for . The deal was made on 22-Aug-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Catalyst Oncology | 22-Aug-2007 | Merger/Acquisition | Consulting Services (B2B) |
DiagnoCure FAQs
-
When was DiagnoCure founded?
DiagnoCure was founded in 1994.
-
Where is DiagnoCure headquartered?
DiagnoCure is headquartered in Quebec, Canada.
-
What is the size of DiagnoCure?
DiagnoCure has 11 total employees.
-
What industry is DiagnoCure in?
DiagnoCure’s primary industry is Diagnostic Equipment.
-
Is DiagnoCure a private or public company?
DiagnoCure is a Public company.
-
What is DiagnoCure’s stock symbol?
The ticker symbol for DiagnoCure is DGCRF.
-
What is DiagnoCure’s current revenue?
The trailing twelve month revenue for DiagnoCure is $5.02M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
